BioTryp Therapeutics

Private

CambridgeHealthcare & Life Scienceshttps://biotryp.com/

Last Round

Grant

Nov 24, 2025

Total Funding Raised

$940,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BioTryp Therapeutics is a biotechnology company developing novel oral antibiofilm therapies for bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

anti-biofilm therapysmall-molecule inhibitorbacterial biofilmantibiotic resistancesuperbugsurinary tract infectionUTIpreclinical drug discoveryantibiotic enhancernon-antibiotic therapydrug licensingbiotechbiofilm busterAI drug discoverymedicinal chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioTryp Therapeutics Comps

Public and private peers based on sector, stage, and business model.

BioTryp Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioTryp Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 24, 2025
Pre Seed	Aug 15, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Ashraf Zarkan

CEO & Co-Founder

Founding Team

BioTryp Therapeutics Investors

Notable investors and investment history

BioTryp Therapeutics investors
Investor	Rounds
Founders at the University of Cambridge	Pre Seed
QUBIS	Pre Seed
National Research Council Canada Industrial Research Assistance Program	Grant
Innovate UK	Grant
Cambridge Enterprise	Pre Seed
Parkwalk Advisors	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 24, 2025
$540K raised from Innovate UK and NRC IRAP.
Aug 15, 2024
$400K raised from Parkwalk Advisors and QUBIS.

View all signals

BioTryp Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioTryp Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioTryp Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge

Employee Range4

Year Founded2024

Last FundingNov 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.